Literature DB >> 12394798

HIV incidence in the United States, 1978-1999.

Minh Quan Vu1, Richard W Steketee, Linda Valleroy, Hillard Weinstock, John Karon, Robert Janssen.   

Abstract

CONTEXT: HIV incidence measurements, which reflect recent or current transmission, are valuable for monitoring the epidemic and evaluating prevention programs.
OBJECTIVES: To summarize HIV incidence patterns and trends in U.S. population groups. DATA SOURCES: Publications in English from 1980 through mid-2000. STUDY SELECTION AND STATISTICAL
METHODS: We searched the literature for reports of HIV incidence in the United States. Locally weighted scatterplot smoothing was used to generate smooth curves to estimate trends in incidence. Spearman rank correlation was used to estimate the correlation coefficient between prevalence and incidence. DATA SYNTHESIS: In 74 eligible reports, HIV incidence varied widely (0.002-19.8 per 100 person-years [py]) depending on risk group. Among men who have sex with men (MSM), HIV incidence peaked in the early 1980s (5-20/100 py) and then declined but remained high during the 1990s (2-4/100 py). Among injection drug users (IDUs), incidence decreased since the mid-1980s but differed by geographic area; in the 1990s, incidence remained high in the East (1-3/100 py) but was lower in the West (<0.5/100 py). Throughout the late 1980s and 1990s, incidence was low and stable in broader populations (blood donors: <0.01/100 py; military personnel: 0.01-0.07/100 py). The correlation between HIV incidence and prevalence was strong in populations with a prevalence less than 1% (r = 0.94, p<.0001), moderate in populations with a prevalence from 1% to less than 10% (r = 0.57, p<.0001), and weak in populations with a prevalence at least 10% (r = 0.23, p=.09).
CONCLUSIONS: HIV prevention in the United States should continue to focus on MSM and IDUs. HIV incidence measurements should be considered for monitoring HIV transmission in MSM, IDUs, and other populations in which seroprevalence is high.

Entities:  

Mesh:

Year:  2002        PMID: 12394798     DOI: 10.1097/00126334-200210010-00010

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  12 in total

Review 1.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

2.  Geospatial methods for identification of core groups for HIV/AIDS.

Authors:  Richard A Scribner; Sandy A Johnson; Deborah A Cohen; William Robinson; Thomas A Farley; Paul Gruenewald
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

3.  HIV prevention services received at health care and HIV test providers by young men who have sex with men: an examination of racial disparities.

Authors:  Stephanie K Behel; Duncan A MacKellar; Linda A Valleroy; Gina M Secura; Trista Bingham; David D Celentano; Beryl A Koblin; Marlene Lalota; Douglas Shehan; Lucia V Torian
Journal:  J Urban Health       Date:  2008-07-12       Impact factor: 3.671

Review 4.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

5.  The cost-effectiveness of expanded testing for primary HIV infection.

Authors:  Andrew Coco
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

6.  Prevalence of primary HIV infection in symptomatic ambulatory patients.

Authors:  Andrew Coco; Emily Kleinhans
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

7.  Monitoring the incidence of HIV infection in the United States.

Authors:  Lisa M Lee; Matthew T McKenna
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

8.  Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.

Authors:  Mark H Kuniholm; Malvina Aladashvili; Carlos Del Rio; Ketavan Stvilia; Nino Gabelia; Rohit A Chitale; Tengiz Tsertsvadze; Kenrad E Nelson
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

Review 9.  Engaging HIV care providers in conversations with their reproductive-age patients about fertility desires and intentions: a historical review of the HIV epidemic in the United States.

Authors:  Riley J Steiner; Sarah Finocchario-Kessler; Jacinda K Dariotis
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

10.  Illicit drug use and HIV treatment outcomes in a US cohort.

Authors:  Joseph Cofrancesco; Rebecca Scherzer; Phyllis C Tien; Cynthia L Gibert; Heather Southwell; Stephen Sidney; Adrian Dobs; Carl Grunfeld
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.